Merck & Co.

merck

Biotech

Merck pays $9.2B for owner of flu antiviral J&J rejected

Merck & Co. is spending $9.2 billion for Cidara Therapeutics and its lead influenza antiviral that was dropped by Johnson & Johnson last year.

James Waldron Nov 14, 2025 8:25am

cancer ribbons world cancer day cancer awareness

Promega wins FDA OK as Keytruda-Lenvima companion diagnostic

Nov 13, 2025 4:00am

Merck Co

Merck's PCSK9 drug mounts injectable-like cholesterol reductions

Nov 10, 2025 10:59am

graphic image of different colored hands shaking

Merck bags $700M from Blackstone, spends $150M to regain asset

Nov 4, 2025 9:15am

Red arrow decreasing

Neuphoria nixes social anxiety program after phase 3 flop

Oct 21, 2025 10:44am

Blue race track

Fierce Pharma

Merck grows more ambitious about 'workhorse' TROP2 ADC

Oct 20, 2025 4:00pm